RxDoctor Payments DataLook up a doctor →

SUFLAVE: payments to doctors

Payments that named SUFLAVE as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$265K
Providers
6,707
Transactions
12,095
Average per transaction
$22

The per-transaction average — $22 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 6,707 providers the average total is $40, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Braintree Laboratories, Inc.$261,57898.7%
Azurity Pharmaceuticals, Inc.$3,3481.3%
Sebela Pharmaceuticals Inc.$1040.0%
← All drugs & devices